NUVEEN ASSET MANAGEMENT, LLC – Abbott Laboratories Transaction History
NUVEEN ASSET MANAGEMENT, LLC portfolio value:
$1.06B
portfolio value
NUVEEN ASSET MANAGEMENT, LLC quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -2.44% | -274.36K shares | -160.13M | $96.76 | 10.96M |
Q2 2022 | share | Increase | +8.86% | 914.70K shares | -35.91M | $108.65 | 11.23M |
Q1 2022 | share | Decrease | -10.02% | -1.14M shares | -357.60M | $118.36 | 10.32M |
Q4 2021 | share | Increase | +16.32% | 1.60M shares | 449.45M | $141 | 11.46M |
Q3 2021 | share | Increase | +15.25% | 1.30M shares | 172.90M | $117.68 | 9.85M |
Q2 2021 | share | Decrease | -3.09% | -272.70K shares | -66.13M | $115.05 | 8.55M |
Q1 2021 | share | Decrease | -5.83% | -546.64K shares | 31.51M | $118.49 | 8.82M |
Q4 2020 | share | Increase | +0.04% | 4.19K shares | 6.64M | $107.81 | 9.37M |
Q3 2020 | share | Decrease | -7.23% | -729.92K shares | 96.31M | $106.81 | 9.37M |
Q2 2020 | share | Increase | +4.16% | 403.27K shares | 158.28M | $89.39 | 10.10M |
Q2 2020 | call | Decrease | -100.00% | -40.8K shares | -3K | $89.39 | 0 |
Q1 2020 | call | Increase | 0.00% | 40.8K shares | 3K | $76.84 | 40.8K |
Q1 2020 | share | Decrease | -11.66% | -1.28M shares | -188.32M | $76.84 | 9.69M |
Q4 2019 | share | Decrease | -6.55% | -769.05K shares | -29.32M | $84.23 | 10.97M |
Q3 2019 | share | Decrease | -5.10% | -631.04K shares | -58.12M | $80.81 | 11.74M |
Q2 2019 | share | Increase | +7888.60% | 12.22M shares | 1.02B | $80.92 | 12.37M |
Q1 2019 | share | Decrease | -0.95% | -1.48K shares | 1.07M | $76.6 | 154.94K |
Q4 2018 | share | Decrease | -1.07% | -1.69K shares | -285K | $68.98 | 156.43K |
Q3 2018 | share | Increase | +4.11% | 6.24K shares | 2.33M | $69.69 | 158.12K |
Q2 2018 | share | Increase | +29.44% | 34.54K shares | 2.23M | $57.68 | 151.88K |
Q1 2018 | share | Decrease | -0.15% | -180 shares | 324K | $56.4 | 117.33K |
Q4 2017 | share | Decrease | -0.59% | -702 shares | 399K | $53.46 | 117.51K |
Q3 2017 | share | Decrease | -1.48% | -1.77K shares | 475K | $49.74 | 118.21K |
Q2 2017 | share | Decrease | -28.80% | -48.54K shares | -1.65M | $45.07 | 119.98K |
Q1 2017 | share | Decrease | -51.75% | -180.72K shares | -5.93M | $40.93 | 168.53K |
Q4 2016 | share | Increase | +80.84% | 156.12K shares | 5.24M | $35.17 | 349.25K |
Q3 2016 | share | Increase | +0.12% | 235 shares | 584K | $38.48 | 193.12K |
Q2 2016 | share | Decrease | -1.33% | -2.60K shares | -594K | $35.55 | 192.89K |
Q1 2016 | share | Decrease | -70.79% | -473.68K shares | -21.87M | $37.6 | 195.49K |